The future of molecular dynamics simulations in drug discovery

被引:0
作者
David W. Borhani
David E. Shaw
机构
[1] D. E. Shaw Research,Center for Computational Biology and Bioinformatics
[2] Columbia University,undefined
来源
Journal of Computer-Aided Molecular Design | 2012年 / 26卷
关键词
Drug discovery; Molecular dynamics simulations; Grand challenges; Free energy;
D O I
暂无
中图分类号
学科分类号
摘要
Molecular dynamics simulations can now track rapid processes—those occurring in less than about a millisecond—at atomic resolution for many biologically relevant systems. These simulations appear poised to exert a significant impact on how new drugs are found, perhaps even transforming the very process of drug discovery. We predict here future results we can expect from, and enhancements we need to make in, molecular dynamics simulations over the coming 25 years, and in so doing set out several Grand Challenges for the field. In the context of the problems now facing the pharmaceutical industry, we ask how we can best address drug discovery needs of the next quarter century using molecular dynamics simulations, and we suggest some possible approaches.
引用
收藏
页码:15 / 26
页数:11
相关论文
共 332 条
[1]  
Marshall GR(1987)Computer-aided drug design Annu Rev Pharmacol Toxicol 27 193-213
[2]  
Van Drie JH(2007)Computer-aided drug design: the next 20 years J Comput Aided Mol Des 21 591-601
[3]  
Martin YC(1981)A practitioner’s perspective of the role of quantitative structure-activity analysis in medicinal chemistry J Med Chem 24 229-237
[4]  
Corey EJ(1969)Computer-assisted design of complex organic syntheses Science 166 178-192
[5]  
Wipke WT(1988)MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric properties J Comput Aided Mol Des 2 15-29
[6]  
Martin YC(2009)Lessons from 60 years of pharmaceutical innovation Nat Rev Drug Discov 8 959-968
[7]  
Danaher EB(2006)Drug discovery in jeopardy J Clin Invest 116 2837-2842
[8]  
May CS(2009)Pedro Cuatrecasas Nat Rev Drug Discov 8 446-214
[9]  
Weininger D(2011)Lessons from 54 years of pharmaceutical research Nat Rev Drug Discov 10 963-916
[10]  
Munos B(2010)How to improve R&D productivity: the pharmaceutical industry’s grand challenge Nat Rev Drug Discov 9 203-329